Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo Network Comparison Type description Value Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2151 to 2200 of 8289 in total 
Network Comparison Type: Divided
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1076\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
COPZ1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
coatomer zeta-1 subunit (zeta-1 coat protein) (zeta-1 cop) (cgi-120) (hspc181). [source:swissprot;acc:q9y3c3]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
174.387\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
179.697\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03045\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SGCZ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sarcoglycan zeta; zeta-sarcoglycan. [source:refseq;acc:nm\_139167]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.757\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
201.939\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02386\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1077\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARCN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
coatomer delta subunit (delta-coat protein) (delta-cop) (archain). [source:swissprot;acc:p48444]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
174.387\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
179.697\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03045\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
FZD5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
frizzled 5 precursor (frizzled-5) (fz-5) (hfz5) (fze5). [source:swissprot;acc:q13467]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.587\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
201.773\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02386\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1078\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
KDELR2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
er lumen protein retaining receptor 2 (kdel receptor 2) (elp-1). [source:swissprot;acc:p33947]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
202.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.191\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PPIE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase e (ec 5.2.1.8) (ppiase e) (rotamase e) (cyclophilin e) (cyclophilin 33). [source:swissprot;acc:q9unp9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
174.387\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
179.697\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.03045\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1079\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
COPZ2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
coatomer zeta-2 subunit (zeta-2 coat protein) (zeta-2 cop). [source:swissprot;acc:q9p299]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
KDELR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
er lumen protein retaining receptor 1 (kdel receptor 1). [source:swissprot;acc:p24390]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.191\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02386\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1080\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRP44L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
brain protein 44-like protein (hspc040) (cgi-129) (pnas-115). [source:swissprot;acc:q9y5u8]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
196.378\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
191.803\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02385\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZNF444\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 444; endothelial zinc finger protein 2. [source:refseq;acc:nm\_018337]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
269.896\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
278.093\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03037\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1081\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF3C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 8 (eif3 p110) (eif3c). [source:swissprot;acc:q99613]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.253\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02384\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
FAU\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s30. [source:swissprot;acc:q05472]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.875\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03027\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1082\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
HDC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.804\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.058\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02384\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PLEKHF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phafin 2; ph and fyve domain-containing protein 2. [source:refseq;acc:nm\_024613]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
220.118\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
213.685\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.03011\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1083\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRD5A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3-oxo-5-alpha-steroid 4-dehydrogenase 1 (ec 1.3.99.5) (steroid 5-alpha-reductase 1) (sr type 1) (s5ar). [source:swissprot;acc:p18405]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TPPP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein p25-beta. [source:swissprot;acc:p59282]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.939\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.193\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02383\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1084\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELOVL6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elovl family member 6, elongation of long chain fatty acids (fen1/elo2, sur4/elo3-like, yeast); long-chain fatty-acyl elongase. [source:refseq;acc:nm\_024090]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
200.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.716\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SRD5A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3-oxo-5-alpha-steroid 4-dehydrogenase 2 (ec 1.3.99.5) (steroid 5-alpha-reductase 2) (sr type 2) (5 alpha-sr2). [source:swissprot;acc:p31213]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.118\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.685\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03011\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1085\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DKC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dyskerin (nucleolar protein nap57) (cbf5 homolog). [source:swissprot;acc:o60832]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
231.007\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
237.864\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02968\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TPPP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
25 kda brain-specific protein (p25-alpha). [source:swissprot;acc:o94811]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.933\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.188\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02382\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1086\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to zinc finger protein 277. [source:sptrembl;acc:q8wwa6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.679\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
243.679\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02958\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TPPP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-38. [source:swissprot;acc:q9bw30]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.157\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02382\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1087\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 277. [source:swissprot;acc:q9nrm2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.679\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
243.679\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02958\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PERLD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cab2. [source:refseq;acc:nm\_033419]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.375\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.715\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02381\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1088\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANXA11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
annexin a11 (annexin xi) (calcyclin-associated annexin 50) (cap-50) (56 kda autoantigen). [source:swissprot;acc:p50995]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.378\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0295\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
DEGS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sphingolipid delta 4 desaturase; membrane fatty acid (lipid) desaturase; dihydroceramide desaturase. [source:refseq;acc:nm\_003676]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.333\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.607\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0238\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1089\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSTF3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cleavage stimulation factor subunit 3; cleavage stimulation factor, 3' pre-rna, subunit 3, 77kd. [source:refseq;acc:nm\_001326]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
121.428\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
125.004\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02945\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TRIB3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuronal cell death inducible putative kinase (skip3). [source:swissprot;acc:q96ru7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.522\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.791\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0238\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1090\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to ribosomal protein, large, p0. [source:sptrembl;acc:q96fq9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.218\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232.88\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02945\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TRIB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
g-protein-coupled receptor induced protein. [source:refseq;acc:nm\_025195]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.79\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1091\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
block 23. [source:sptrembl;acc:q8nhw5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.205\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232.858\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02941\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
CPT1C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carnitine palmitoyltransferase i related c. [source:refseq;acc:nm\_152359]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.519\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.789\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1092\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPHB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ephrin type-b receptor 1 precursor (ec 2.7.1.112) (tyrosine-protein kinase receptor eph-2) (net) (hek6) (elk). [source:swissprot;acc:p54762]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
210.722\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.826\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RPLP0\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s acidic ribosomal protein p0 (l10e). [source:swissprot;acc:p05388]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.203\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232.855\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02941\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1093\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
COPA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
coatomer alpha subunit (alpha-coat protein) (alpha-cop) (hepcop) (hep-cop) [contains: xenin (xenopsin-related peptide); proxenin]. [source:swissprot;acc:p53621]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
177.432\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
182.647\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02939\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
EPHA5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ephrin type-a receptor 5 precursor (ec 2.7.1.112) (tyrosine-protein kinase receptor ehk-1) (eph homology kinase-1) (receptor protein- tyrosine kinase hek7). [source:swissprot;acc:p54756]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.722\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.826\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1094\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANXA7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
annexin a7 (annexin vii) (synexin). [source:swissprot;acc:p20073]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.655\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.385\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02938\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
EPHA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ephrin type-a receptor 2 precursor (ec 2.7.1.112) (tyrosine-protein kinase receptor eck) (epithelial cell kinase). [source:swissprot;acc:p29317]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.722\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.826\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1095\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
GTPBP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial gtp binding protein isoform v. [source:refseq;acc:nm\_032620]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.552\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
207.463\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02935\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SLC7A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
high-affinity cationic amino acid transporter-1 (cat-1) (cat1) (system y+ basic amino acid transporter) (ecotropic retroviral leukemia receptor homolog) (err) (ecotropic retrovirus receptor homolog). [source:swissprot;acc:p30825]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.661\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
195.999\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1096\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPHA7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ephrin type-a receptor 7 precursor (ec 2.7.1.112) (tyrosine-protein kinase receptor ehk-3) (eph homology kinase-3) (receptor protein- tyrosine kinase hek11). [source:swissprot;acc:q15375]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
210.722\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.826\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFB9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase b22 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b22) (ci-b22). [source:swissprot;acc:q9y6m9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.345\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
206.339\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02911\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1097\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP2C2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable calcium-transporting atpase kiaa0703 (ec 3.6.3.8). [source:swissprot;acc:o75185]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
209.123\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.208\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
EPHB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ephrin type-b receptor 2 precursor (ec 2.7.1.112) (tyrosine-protein kinase receptor eph-3) (drt) (receptor protein-tyrosine kinase hek5) (erk). [source:swissprot;acc:p29323]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.722\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.826\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1098\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
AP3M1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adapter-related protein complex 3 mu 1 subunit (mu-adaptin 3a) (ap-3 adapter complex mu3a subunit). [source:swissprot;acc:q9y2t2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.323\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
211.185\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02906\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
EPHA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ephrin type-a receptor 4 precursor (ec 2.7.1.112) (tyrosine-protein kinase receptor sek) (receptor protein-tyrosine kinase hek8). [source:swissprot;acc:p54764]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.722\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.826\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1099\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
AP3M2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adapter-related protein complex 3 mu 2 subunit (clathrin coat assembly protein ap47 homolog 2) (clathrin coat associated protein ap47 homolog 2) (golgi adaptor ap-1 47 kda protein homolog 2) (ha1 47 kda subunit homolog 2) (clathrin assembly protein assembly protein complex 1 medium chain homolog 2) (p47b). [source:swissprot;acc:p53677]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.315\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
211.183\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02904\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
CPT1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carnitine o-palmitoyltransferase i, mitochondrial liver isoform (ec 2.3.1.21) (cpt i) (cpti-l). [source:swissprot;acc:p50416]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.519\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.789\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02379\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1100\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ephrin type-b receptor 4 precursor (ec 2.7.1.112) (tyrosine-protein kinase receptor htk). [source:swissprot;acc:p54760]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
210.722\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
205.826\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ATP2C1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
calcium-transporting atpase type 2c, member 1 (ec 3.6.3.8) (atpase 2c1) (atp-dependent ca(2+) pump pmr1) (hussy-28). [source:swissprot;acc:p98194]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.052\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.183\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02889\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/